UK-based Aestimo Technologies Limited has launched the Aestimo Technologies Luxembourg Fund SA SICAV-RAIF.
MJ Hudson acted as legal counsel to Aestimo on the launch of the fund, which aims to harness quantitative techniques to extract profits from conditional inefficiencies in the European main equity markets through short-term directional positions.
Co-founder, co-CEO and COO of Aestimo Technologies Limited, Olivier Varon, says: “MJ Hudson was mandated after a thorough selection process, inspired by the methodological approaches for which we are known. We wanted a firm that has a true comprehension of start-up constraints and that was able to provide legal advice that satisfied our institutional requirements. We found this combination in MJ Hudson.”
The fund is structured as a Luxembourg Reserved Alternative Investment Fund with two sub-funds: Aestec 1 (the main fund) and Aestec 2, which is a three-times leveraged version of the strategy of Aestec 1. Shares in Aestec 2 are only available to existing investors in Aestec 1, once a minimum excess performance threshold has been reached.
Dr Georges Duponcheele, co-founder, co-CEO and CIO of Aestimo Technologies Limited, adds: “MJ Hudson is staffed by dedicated and versatile professionals who translated in legal terms our technical innovation embedded in the way the two sub-funds interact. I can see lots of potential for our relationship to develop further.”
MJ Hudson’s team was led by Sean Scott, with support from Emmanuel Amos, Robert Eke and Kemi Greene.
Scott says: “We are delighted to have acted as legal counsel for this fund launch and we wish the Aestimo team the best of luck for the next stage of their business’ growth.”
